Carroll Financial Associates’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-42
| Closed | – | – | 1808 |
|
|
2019
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1801 |
|
|
2019
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1846 |
|
|
2019
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1814 |
|
|
2019
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 1607 |
|
|
2018
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1465 |
|
|
2018
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1410 |
|
|
2018
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1385 |
|
|
2018
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 1410 |
|
|
2017
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1357 |
|
|
2017
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1344 |
|
|
2017
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1312 |
|
|
2017
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 1306 |
|
|
2016
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1294 |
|
|
2016
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1311 |
|
|
2016
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1312 |
|
|
2016
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 1316 |
|
|
2015
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1241 |
|
|
2015
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1250 |
|
|
2015
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1187 |
|
|
2015
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 908 |
|
|
2014
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 1011 |
|
|
2014
Q3 | $0 | Hold |
42
| – | – | ﹤0.01% | 1049 |
|
|
2014
Q2 | $0 | Hold |
42
| – | – | ﹤0.01% | 1008 |
|
|
2014
Q1 | $0 | Hold |
42
| – | – | ﹤0.01% | 1020 |
|
|
2013
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 997 |
|
|
2013
Q3 | $0 | Buy |
+42
| New | +$80 | ﹤0.01% | 931 |
|
Carroll Financial Associates's GCVRZ Position: Q1 2020 in Review
Carroll Financial Associates sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 42 shares.
Carroll Financial Associates first reported a position in GCVRZ in Q3 2013 and held it in 26 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Carroll Financial Associates reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Carroll Financial Associates sold 42 Sanofi Contingent Value Rights shares in Q1 2020.
- Carroll Financial Associates first reported a position in Sanofi Contingent Value Rights in Q3 2013 and held it in 26 quarters.
- Carroll Financial Associates's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Carroll Financial Associates's 13F filing for Q1 2020, filed 10 Apr 2020.